PROOF’s Biomarkers in Transplantation (BiT) program focuses on applying a novel multi-gene blood test to the management of acute cardiac allograft rejection, with the end goal of improving patient management while reducing the need for biopsies. Congratulations to Dr. McManus and the PROOF team for the excellent work!

Congratulations also to the other CIHR grant recipients from this round of competition.